Clinical Trials in Austin

Showing 5041-5060 of 11,561 trials

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

NCT03775512

Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to demonstrate the safety and effectiveness when compared to an historical control performance goal.

Paroxysmal Atrial Fibrillation

Biosense Webster, Inc.283 participantsStarted Jan 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Atlantis, Florida, United States +19 more locations

TERMINATEDNA17 miles

OPTIMIZE IDE for the Treatment of ACS

NCT03190473

Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Acute Coronary Syndrome

Svelte Medical Systems, Inc.1,630 participantsStarted Jan 2018

Fairhope, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +69 more locations

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

OPTIMIZE IDE for the Treatment of ACS

Find Trials by Condition in Austin

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

FREEDOM COVID-19 Anticoagulation Strategy

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

The TREFOIL Concept 5 Year Clinical Investigation